Entera Bio Analyst Ratings
Entera Bio Analyst Ratings
While ratings are subjective and will change, the latest Entera Bio (ENTX) rating was a reiterated with a price target of $0.00 to $10.00. The current price Entera Bio (ENTX) is trading at is $0.63, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/11/2023 | 1487.3% | HC Wainwright & Co. | → $10 | Reiterates | Buy → Buy |
| 05/08/2023 | 1487.3% | HC Wainwright & Co. | → $10 | Reiterates | → Buy |
| 04/04/2023 | 1487.3% | HC Wainwright & Co. | → $10 | Reiterates | → Buy |
| 03/28/2023 | 1487.3% | HC Wainwright & Co. | → $10 | Reiterates | → Buy |
| 09/06/2022 | 1487.3% | HC Wainwright & Co. | → $10 | Initiates Coverage On | → Buy |
| 07/19/2022 | 693.65% | B. Riley Securities | $6 → $5 | Maintains | Buy |
| 06/16/2021 | 1328.57% | B. Riley Securities | → $9 | Initiates Coverage On | → Buy |
| 03/22/2021 | 1804.76% | Aegis Capital | → $12 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 09/11/2023 | 1487.3% | HC Wainwright公司 | →$10 | 重申 | 购买→购买 |
| 05/08/2023 | 1487.3% | HC Wainwright公司 | →$10 | 重申 | →购买 |
| 04/04/2023 | 1487.3% | HC Wainwright公司 | →$10 | 重申 | →购买 |
| 03/28/2023 | 1487.3% | HC Wainwright公司 | →$10 | 重申 | →购买 |
| 09/06/2022 | 1487.3% | HC Wainwright公司 | →$10 | 开始承保 | →购买 |
| 07/19/2022 | 693.65% | B.莱利证券 | $6→$5 | 维护 | 买 |
| 06/16/2021 | 1328.57% | B.莱利证券 | →$9 | 开始承保 | →购买 |
| 03/22/2021 | 1804.76% | 宙斯盾资本 | →$12 | 开始承保 | →购买 |
What is the target price for Entera Bio (ENTX)?
Entera Bio的目标价是多少？
The latest price target for Entera Bio (NASDAQ: ENTX) was reported by HC Wainwright & Co. on September 11, 2023. The analyst firm set a price target for $10.00 expecting ENTX to rise to within 12 months (a possible 1487.30% upside). 4 analyst firms have reported ratings in the last year.
HC Wainwright&Co.于2023年9月11日报道了Entera Bio(纳斯达克代码：ENTX)的最新目标价。这家分析公司将目标价定为10美元，预计ENTX将在12个月内上涨至(可能上涨1487.30%)。去年有4家分析公司公布了评级。
What is the most recent analyst rating for Entera Bio (ENTX)?
分析师对Entera Bio的最新评级是多少？
The latest analyst rating for Entera Bio (NASDAQ: ENTX) was provided by HC Wainwright & Co., and Entera Bio reiterated their buy rating.
纳斯达克(股票代码：ENTX)的最新分析师评级由HC Wainwright&Co.提供，Entera Bio重申其买入评级。
When is the next analyst rating going to be posted or updated for Entera Bio (ENTX)?
Entera Bio(ENTX)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Entera Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Entera Bio was filed on September 11, 2023 so you should expect the next rating to be made available sometime around September 11, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Entera Bio的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Entera Bio的上一次评级是在2023年9月11日提交的，所以你应该预计下一次评级将在2024年9月11日左右提供。
Is the Analyst Rating Entera Bio (ENTX) correct?
分析师对Entera Bio的评级正确吗？
While ratings are subjective and will change, the latest Entera Bio (ENTX) rating was a reiterated with a price target of $0.00 to $10.00. The current price Entera Bio (ENTX) is trading at is $0.63, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Entera Bio(ENTX)评级被重申，目标价在0.00美元至10.00美元之间。Entera Bio目前的交易价格为0.63美元，在分析师的预测范围内。
